A client is admitted with protein-calorie malnutrition and is receiving supplemental feedings through a naso-duodenal tube. Which assessment finding indicates that the client's nutritional status is improving?

Glipizide is an oral antidiabetic medication commonly prescribed to manage type 2 diabetes. It works by stimulating the release of insulin from the pancreas, which helps lower blood glucose levels. However, there is a risk of hypoglycemia (low blood sugar) with the use of Glipizide.

It is crucial for the client to be aware of the signs and symptoms of hypoglycemia so that they can take appropriate action if their blood sugar drops too low. These symptoms may include sweating, trembling, dizziness, confusion, weakness, and hunger. By recognizing these signs, the client can promptly address hypoglycemia by consuming a source of fast-acting glucose, such as fruit juice or glucose tablets, as instructed by their healthcare provider.

In a client with minimal change nephrotic syndrome (MCNS), the primary concern is the management of fluid volume and hydration status. MCNS is characterized by increased glomerular permeability, leading to excessive protein loss in the urine and subsequent hypoalbuminemia. This can result in fluid retention and edema formation, including facial edema.

Hypertension is a common complication in clients with MCNS, and it further contributes to fluid retention and potential complications. Therefore, closely monitoring the client's fluid volume and hydration status, including daily weights, intake and output measurements, and assessment of edema, is crucial to detect any changes and guide appropriate interventions.

While other actions, such as consulting with a registered dietitian about adequate intake or using sterile technique to prevent infections, may be important aspects of the client's care, they are not the priority in this situation. The immediate concern is managing the client's hypertension and fluid volume status to prevent complications associated with MCNS.